Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Not Dead Yet Applauds Second Thoughts Connecticut As Disability Advocates Prepare to Testify Against Assisted Suicide Bill
  • USA - English


News provided by

Not Dead Yet

Mar 18, 2015, 05:00 ET

Share this article

Share toX

Share this article

Share toX

Stephen Mendelsohn Testifies
Stephen Mendelsohn Testifies

Hartford, CT (PRWEB) March 18, 2015 -- Not Dead Yet applauds Second Thoughts Connecticut, as disability advocates held a press conference Monday and now prepare to testify against an assisted suicide bill (HB 7015) at a Connecticut House Judiciary Committee hearing being held on Wednesday, March 18, 2015. Not Dead Yet’s New England regional director John Kelly is also submitting written testimony opposed to the bill.

Mercilessly bullied autistic and LGBT youth can pick up this message that ‘my death’ is ‘my choice’ . . . and act on it. Those of us on the autism spectrum can take messages like this quite literally.

Post this

Both proponents and opponents of the Connecticut assisted suicide bill held press conferences on Monday at the state capitol. One speaker who opposes the legislation was Maggie Karner, a woman with brain cancer, who was quoted saying “if we endorse patient suicide as our statewide policy for dealing with pain and the financial burdens at the end of life — we’re going to end up embracing a whole new ethic that confuses compassionate medical care with a prescription for death.” (Both Sides Get Ready To Debate End of Life Issues, CT News Junkie, March 16, 2015.)

One of the leaders of Second Thoughts CT, Cathy Ludlum, was interviewed extensively about her concerns as a person with significant physical disabilities regarding the potential for "unintended consequences" and the difficulty of providing adequate safeguards. She noted that terminal prognoses can be incorrect. Regarding safeguards, “Ludlum pointed to studies that indicate as many as one in 10 seniors are victims of elder abuse. 'If you’re introducing a deadly prescription into that family situation, where no one is going to be there to see what happens, you don’t know what happened,' she said." Ludlum also noted that cost cutting pressures in health care and social services could "push some people toward ending their lives.” (On polarizing end-of-life issue, what changes minds? CT Mirror, March 16, 2015)

Second Thoughts CT disability advocates have been also preparing for a hearing on the bill before the House Judiciary Committee. The testimony of Stephen Mendelsohn, another Second Thoughts CT leader, raises serious concerns about suicide contagion in Oregon, where assisted suicide is legal. “According to the Centers for Disease Control, Oregon’s already high suicide rate has increased much more than the national average; from 1999 (shortly after the Oregon Death with Dignity Act took effect) until 2010, the rate of increase for people age 35-64 was 49% in Oregon versus 28% nationally. . . . Mercilessly bullied autistic and LGBT youth can pick up this message that ‘my death’ is ‘my choice’ . . . and act on it. Those of us on the autism spectrum can take messages like this quite literally.”

Mendelsohn’s testimony also points to the dangers of future expansion of eligibility for assisted suicide beyond the parameters in the current bill, based on public comments by assisted suicide proponents:

“When Compassion & Choices president Barbara Coombs Lee came to Hartford last October, she declared her support for assisted suicide for people with dementia and cognitive disabilities unable to consent. CT News Junkie quoted her saying, ‘It is an issue for another day but is no less compelling.’ (Compassion & Choices Draws Full House at Real Art Ways for Panel Discussion, Film, Oct. 10, 2014) Dr. Marcia Angell, leading proponent of the defeated Massachusetts’ assisted suicide ballot question, recently wrote in The New York Review of Books that she now favors euthanasia as well as assisted suicide. (“A Better Way Out,” Jan. 8, 2015.) Oregon is currently debating legislation (HB 3337) that would extend eligibility for assisted suicide from a six month prognosis to one year.”

The Disability Rights Education & Defense Fund’s senior policy analyst Marilyn Golden submitted a compilation of “Some Oregon and Washington State Abuses and Complications.” Hearing testimonies on HB 7015 submitted in advance are available online on the Judiciary Committee's website.

Diane Coleman, Not Dead Yet, http://www.notdeadyet.org, +1 708-420-0539, [email protected]

Modal title

John Kelly/Not Dead Yet Testimony Opposing HB 7015
John Kelly/Not Dead Yet Testimony Opposing HB 7015
Cathy Ludlum/Second Thoughts CT Testimony Opposing HB 7015
Cathy Ludlum/Second Thoughts CT Testimony Opposing HB 7015
Stephen Mendelsohn/Second Thoughts CT Testimony Opposing HB 7015
Stephen Mendelsohn/Second Thoughts CT Testimony Opposing HB 7015
John Kelly/Not Dead Yet Testimony Opposing HB 7015 Cathy Ludlum/Second Thoughts CT Testimony Opposing HB 7015 Stephen Mendelsohn/Second Thoughts CT Testimony Opposing HB 7015

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.